pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News mentioning Immunology
89
stories
Jul 14, 26
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
biopharma dive
Jul 14, 26
STAT+: Anthropic’s Claude Science is coming for Kendall Square
stat
Jul 14, 26
Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response
stat
Jul 14, 26
STAT+: Akero team, backed by Fairmount, launches new immunology company
stat
Jul 14, 26
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
biopharma dive
Jul 9, 26
Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfront
endpoints
Jul 6, 26
Cancer, immune drugmakers dominate VC funding so far in 2026
biopharma dive
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Beeline adds $126M to Bain-backed immunology pipeline from Bristol Myers
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 18, 26
Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
biopharma dive
Jun 8, 26
Nurix to work with Roche on BTK degrader in pact worth up to $2.3B
endpoints
Jun 2, 26
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
stat
May 12, 26
Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
biopharma dive
May 12, 26
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
stat
May 8, 26
Lilly, Gilead lead pharma’s M&A boom
biopharma dive
May 8, 26
Odyssey, on second try, snags $279M in an IPO
biopharma dive
May 6, 26
Avalo scores Phase 2 success in comeback bid, raises $375M
endpoints
May 1, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Apr 29, 26
AbbVie faces questions about Skyrizi competition from J&J
endpoints
Apr 25, 26
Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
stat
Apr 25, 26
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
endpoints
Apr 24, 26
Opinion: The local news crisis is also a public health crisis
stat
Apr 23, 26
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
biopharma dive
Apr 23, 26
STAT+: Sanofi research priorities in flux as new CEO logs in
stat
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
Apr 23, 26
Sanofi defends Garijo appointment, says it is 'fully committed' to immunology
endpoints
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
← prev
page 3 of 3
next →
